ZNO
vs
S
S&P/ASX 300
ZNO
Over the past 12 months, ZNO has significantly outperformed S&P/ASX 300, delivering a return of +84% compared to the S&P/ASX 300's +12% growth.
Stocks Performance
ZNO vs S&P/ASX 300
Performance Gap
ZNO vs S&P/ASX 300
Performance By Year
ZNO vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Zoono Group Ltd
Glance View
Zoono Group Ltd. is a pharmaceutical and biotechnology company. The company is headquartered in Sydney, New South Wales. The firm is focused on developing, manufacturing and distributing of scientifically validated antimicrobial solutions. The firm's products are based on the Zoono molecule, which is an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. The firm's products include sprays, wipes and foams suited for skin care, surface sanitizers, and mould remediation treatments. Its sanitizer products include surface sanitizer and hand sanitizer.
